|
|
Application of echocardiography combined with DTI technology in cardiac function evaluation after hemodialysis and peritoneal dialysis for six months |
LI Fabing QIAN Guangrong |
Department of Nephrology, Ma’anshan People’s Hospital, Anhui Province, Ma’anshan 243000, China |
|
|
Abstract Objective To explore the application of echocardiography combined with Doppler tissue imaging (DTI) technology in evaluating cardiac function after hemodialysis and peritoneal dialysis for six months. Methods A total of 100 patients with end-stage renal disease admitted to Ma’anshan People’s Hospital, Anhui Province, from January 2016 to January 2020 were selected for study. According to different dialysis methods, they were divided into hemodialysis group (60 cases) and peritoneal dialysis group (40 cases). Left ventricular posterior wall thickness (LVPWTd), end diastolic interventricular septum (IVSTd), left ventricular end-systolic diameter (LVDs), left ventricular end-diastolic diameter (LVDd), left atrial diameter (LAD), left ventricular ejection fractions (LVEF), left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), left ventricular short axis shorting rate (FS), stroke output (SV) were measured by echocardiography combined with DTI before and six months after dialysis in both groups. Results There was no significant difference in the results of heart examination between the two groups before dialysis (P > 0.05). After dialysis, LVPWTd, IVSTd, LVDs, LVDd, LAD, LVEDV, LVESV, FS, and SV in both groups were higher than those before dialysis, while LVEF was lower than that before dialysis, LVPWTD, IVSTD, LVEDV and LVESV in the hemodialysis group were higher than those in the peritoneal dialysis group, the differences were statistically significant (all P < 0.05). There were no significant differences in LVDs, LVDd, LAD, FS, SV and LVEF between the two groups after dialysis (P > 0.05). Conclusion Echocardiography combined with DTI indicate that there are changes of cardiac function in dialysis patients, and the changes of cardiac function and morphology in hemodialysis patients are more obvious.
|
|
|
|
|
[1] 赵卫红,柏云,裴小华.老年终末期肾病治疗的选择:透析还是保守[J].肾脏病与透析肾移植杂志,2019,28(6):52-53.
[2] 孙岩,卓燕,余文洪,等.老年终末期肾脏病血透患者长期生存情况及相关影响因素[J].医学临床研究,2018,35(6):1144-1145,1150.
[3] 姜俊,兰雷,周晓婉,等.终末期肾脏病腹膜透析患者长期预后及其透析前危险因素的研究[J].中国血液净化,2017,16(10):676-680.
[4] 兰天,周莉,付平.尿毒症透析患者心血管疾病介入治疗进展[J].中国血液净化,2019,18(12):847-849.
[5] 牛宁宁,唐缨,赵静雯,等.终末期肾病患者左心房功能改变及与左心室功能的相关性研究[J].中国全科医学,2017,20(35):4387-4390.
[6] 陈美珊,汤小芳,倪惜芝,等.超声心动图评价血液透析患者左心功能的价值[J].海南医学,2019,30(12):1575-1577.
[7] 方纪林,蒋红利,李向东,等.不同透析方式对终末期肾脏疾病患者钙磷代谢及炎症因子水平的影响[J].国际泌尿系统杂志,2020,40(1):115-118.
[8] 朱雪丽,苏东美,任文,等.血液透析与腹膜透析对终末期肾病患者血脂、氧化应激及炎症因子的影响[J].标记免疫分析与临床,2019,26(3):371-375.
[9] 苏东美,朱雪丽,任文,等.老年终末期肾病患者行不同透析方式治疗的临床疗效及预后COX回归分析[J].中国中西医结合肾病杂志,2019,20(12):1091-1093.
[10] 袁媛,周莉,袁怀红.血液透析或腹膜透析终末期肾病老年患者的生存预后及其影响因素研究[J].实用医院临床杂志,2017,14(6):264-265.
[11] 饶甲环,马煜盛,龙洁旎,等.肾功能不全致心血管疾病机制的研究进展[J].广东医学,2018,39(15):2388-2390.
[12] 卓建钦.腹膜透析和血液透析对终末期肾病患者心脏结构和功能的影响[J].河北医科大学学报,2019,40(1):38-42.
[13] Bakkalo■lu SA,Kandur Y,Serdaro■lu E,et al. Effect of the timing of dialysis initiation on left ventricular hypertrophy and inflammation in pediatric patients [J]. Pediatr Nephrol,2017,32(9):1595-1602.
[14] Vigan J,Ahoui S,Hounsou D,et al. Left ventricular hypertrophy in chronic hemodialysis patients at CNHU-HKM of Cotonou [J]. Nephrol Ther,2018,14(1):29-34.
[15] 胡勇,赵旭林,张琳,等.心血管疾病风险与C-反应蛋白和肾功能不全之间的临床关系研究[J].山西医药杂志,2017,46(3):328-331.
[16] Toida T,Toida R,Yamashita R,et al. Grading of Left Ventricular Diastolic Dysfunction with Preserved Systolic Function by the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging Recommendations Contributes to Predicting Cardiovascular Events in Hemodialysis Patients [J]. Cardiorenal Med,2019,9(3):190-200.
[17] 余坷珂,程瑞洪,王朝晖,等.超声心动图对尿毒症患者透析前后左心室结构及功能的评价[J].疑难病杂志,2016, 15(4):344-346.
[18] Ersan Demirci D,Demirci D,Coban M,et al. Echocardiographic assessment of right ventricular function in peritoneal dialysis patients [J]. Turk Kardiyol Dern Ars,2019,47(2):88-94.
[19] 符晓丁.超声心动图在高血压心脏病诊断中的应用价值[J].中国当代医药,2018,25(24):118-120.
[20] 刘勤,庞家华,张敏,等.超声心动图评价左房形态和功能的临床应用进展[J].现代生物医学进展,2019,19(15):199-202.
[21] 李燕君,崔健嫦.应用超声心动图与外周血管超声联合诊断高血压心脏病的效果观察[J].中国医药科学,2020, 10(3):217-219.
[22] 金玉明,洪桂荣,孙望星,等.组织多普勒成像技术对原发性高血压病患者左室舒张功能的评价[J].临床超声医学杂志,2016,18(4):268-270.
[23] 陈芗茹,周佳,张庆雨.组织多普勒技术定量评价早产儿合并新生儿呼吸窘迫综合征心功能研究[J].中国现代医生,2019,57(6):90-92,169.
[24] 高丽,郑嘉荣,曹艳,等.超声心动图组织多普勒技术对2型糖尿病左心室功能的研究[J].中国超声医学杂志,2018,34(2):150-152.
[25] 郭金强,黄建,王爽,等.组织多普勒成像评价多囊卵巢综合征患者左室舒张功能的研究[J].临床超声医学杂志,2019,21(7):537-539,564.
[26] 麻冰,虞妙婷,马丽,等.透析方式与维持透析患者生活质量疗效和微炎症指标的相关性[J].河北医学,2020, 26(3):384-389.
[27] 陈林丽,姚春,张萍萍,等.超声彩色脉搏波技术在腹膜透析患者颈动脉弹性定量评估中的应用价值[J].中国现代医生,2020,58(35):125-128.
[28] 李富强.血液透析和腹膜透析对慢性肾衰竭尿毒症患者微炎症状态的影响及与心血管疾病的关系[J].临床内科杂志,2019,36(11):748-750.
[29] 蓝梅金,陈勇平,丘美兰.终末期肾脏病伴肝硬化失代偿患者血液透析和腹膜透析的临床分析[J].中国医药科学,2020,10(23):247-249,254.
[30] 齐玲,孔祥栋,盛丹虹,等.不同透析方式对尿毒症患者血管内皮细胞功能、微炎症状态及心血管并发症的影响[J].浙江医学,2018,40(14):62-64,73. |
|
|
|